112 related articles for article (PubMed ID: 38253021)
1. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
Yang X; Zeng J; Jiang C; Zhang Y; Zhang X
Rev Invest Clin; 2024 Mar; 76(1):6-17. PubMed ID: 38253021
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric cancer cells by activating PKMYT1.
Zhan L; Wu W; Yang Q; Shen H; Liu L; Kang R
Mol Cell Probes; 2023 Dec; 72():101932. PubMed ID: 37729973
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factor E2F7 Hampers the Killing Effect of NK Cells against Colorectal Cancer Cells via Activating RAD18 Transcription.
Jiang B; Yan B; Yang H; Geng H; Li P
J Microbiol Biotechnol; 2024 Apr; 34(4):920-929. PubMed ID: 38073330
[TBL] [Abstract][Full Text] [Related]
4. Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis.
Yuan Y; Zhou X; Kang Y; Kuang H; Peng Q; Zhang B; Liu X; Zhang M
Life Sci; 2021 Feb; 267():118955. PubMed ID: 33359669
[TBL] [Abstract][Full Text] [Related]
5. RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.
Hazar-Rethinam M; de Long LM; Gannon OM; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Saenz-Ponce N; Dantzic DD; Simpson F; Saunders NA
Mol Cancer Ther; 2015 Aug; 14(8):1939-50. PubMed ID: 26018753
[TBL] [Abstract][Full Text] [Related]
6. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription.
Hao F; Wang N; Zhang Y; Xu W; Chen Y; Fei X; Wang J
Mol Carcinog; 2022 Nov; 61(11):975-988. PubMed ID: 35924788
[TBL] [Abstract][Full Text] [Related]
7. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
Zhao Y; Zhu C; Chang Q; Peng P; Yang J; Liu C; Liu Y; Chen X; Liu Y; Cheng R; Wu Y; Wu X; Hu L; Yin J
PLoS One; 2020; 15(11):e0242179. PubMed ID: 33201900
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.
Lu T; Wang R; Cai H; Cui Y
Biomed Pharmacother; 2020 Mar; 123():109650. PubMed ID: 31884338
[TBL] [Abstract][Full Text] [Related]
9. CISD2 transcriptional activated by transcription factor E2F7 promotes the malignant progression of cervical cancer.
Wang L; Wang Y; Wang C; Yang K; Ye G
J Mol Histol; 2023 Oct; 54(5):489-498. PubMed ID: 37615745
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
He Y; Jiang X; Duan L; Xiong Q; Yuan Y; Liu P; Jiang L; Shen Q; Zhao S; Yang C; Chen Y
Mol Cancer; 2021 Dec; 20(1):156. PubMed ID: 34856993
[TBL] [Abstract][Full Text] [Related]
11. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
Wang C; Li S; Xu J; Niu W; Li S
Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
[TBL] [Abstract][Full Text] [Related]
12. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
13. ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
Yang L; Wang H; Guo M; He M; Zhang W; Zhan M; Liu Y
Cell Oncol (Dordr); 2023 Aug; 46(4):1085-1095. PubMed ID: 36988891
[TBL] [Abstract][Full Text] [Related]
14. The protective role of all-transretinoic acid (ATRA) against colorectal cancer development is achieved via increasing miR-3666 expression and decreasing E2F7 expression.
Liu W; Song Y; Zhang C; Gao P; Huang B; Yang J
Biomed Pharmacother; 2018 Aug; 104():94-101. PubMed ID: 29772445
[TBL] [Abstract][Full Text] [Related]
15. E2F7/RAD51AP1 Axis Inhibits Endometrial Cancer Sensitivity to 5-FU
Huang X; Wu Z; Xiao C; Chen XI
Anticancer Res; 2023 Nov; 43(11):4905-4914. PubMed ID: 37909953
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.
Sun QS; Luo M; Zhao HM; Sun H
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4210-4219. PubMed ID: 31173292
[TBL] [Abstract][Full Text] [Related]
17. Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase.
Wang XM; Li QY; Ren LL; Liu YM; Wang TS; Mu TC; Fu S; Liu C; Xiao JY
Cell Signal; 2019 Jul; 59():171-181. PubMed ID: 30953699
[TBL] [Abstract][Full Text] [Related]
18. E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells.
Wang Y; Pei X; Xu P; Tan Z; Zhu Z; Zhang G; Jiang Z; Deng Z
Oncol Rep; 2020 Sep; 44(3):849-862. PubMed ID: 32582990
[TBL] [Abstract][Full Text] [Related]
19. LINC00174 Facilitates Proliferation and Migration of Colorectal Cancer Cells via MiR-3127-5p/ E2F7 Axis.
Ma Y; Li Y; Tang Y; Tang N; Wang D; Li X
J Microbiol Biotechnol; 2021 Aug; 31(8):1098-1108. PubMed ID: 34226413
[TBL] [Abstract][Full Text] [Related]
20. MiR-137 targets and regulates E2F7 to suppress progression of glioma cells.
Li J; Gu J; Wang J; You A; Zhang Y; Rao G; Li S; Ge X; Zhang K; Wu X; Cheng L; Zhu M; Wang D
Folia Neuropathol; 2022; 60(3):346-354. PubMed ID: 36382488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]